ifenprodil has been researched along with Hearing Loss in 1 studies
ifenprodil: NMDA receptor antagonist
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basile, AS | 1 |
| Huang, JM | 1 |
| Xie, C | 1 |
| Webster, D | 1 |
| Berlin, C | 1 |
| Skolnick, P | 1 |
1 other study available for ifenprodil and Hearing Loss
| Article | Year |
|---|---|
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
Topics: Animals; Anti-Bacterial Agents; Cochlea; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Gui | 1996 |